We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$7.25M
Cap. Flow
+$6.12M
Cap. Flow %
5.4%
Top 10 Hldgs %
42.19%
Holding
57
New
16
Increased
8
Reduced
26
Closed
5

Top Buys

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$1.89M
2
NXTM
NxStage Medical Inc.
NXTM
+$1.78M
3
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.75M
4
ESPR
Esperion Therapeutics
ESPR
+$1.72M
5
TVTX icon
Travere Therapeutics
TVTX
+$1.65M

Top Sells

Rank Stock Value
1
ARDX icon
Ardelyx
ARDX
+$2.4M
2
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
+$2.03M
3
LPLA icon
LPL Financial
LPLA
+$1.59M
4
TRN icon
Trinity Industries
TRN
+$1.54M
5
ZGNX
Zogenix, Inc.
ZGNX
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 43.85%
2 Financials 32.05%
3 Technology 5.46%
4 Energy 4.39%
5 Consumer Discretionary 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
51
DELISTED
Seagen Inc. Common Stock
SGEN
$1.23M 1.08%
23,704
-10,948
-32% -$696K
RARX
52
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.18M 1.05%
63,144
-40,462
-39% -$913K
ARDX icon
53
Ardelyx
ARDX
$1.28B
– –
-189,477
Closed -$2.4M
LPLA icon
54
LPL Financial
LPLA
$26B
– –
-39,989
Closed -$1.59M
TRN icon
55
Trinity Industries
TRN
$2.9B
– –
-80,402
Closed -$1.54M
BLCM
56
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-16,461
Closed -$2.03M
FOMX
57
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-203,519
Closed -$1.01M
1 2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q2 2017 Portfolio in Review

As of Q2 2017, Emory University held 57 positions worth $113M, up 6.8% from $106M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Emory University deployed $6.12M of net new capital in Q2 2017, opening 16 new positions and adding to 8 existing holdings. Its largest new stake was Loxo Oncology, Inc: 34,143 shares worth $2.74M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 39% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Zogenix, Inc., an estimated $1.34M trimmed.

  • Emory University's largest Q2 2017 buy was Loxo Oncology, Inc: 34,143 shares worth $2.74M.
  • Emory University added most to Kinder Morgan in Q2 2017, an estimated $144K increase.
  • Emory University's biggest Q2 2017 reduction was Zogenix, Inc., cutting an estimated $1.34M.
  • Emory University fully exited Ardelyx in Q2 2017, selling an estimated $2.4M.
  • Emory University's ten largest holdings make up 42% of its $113M portfolio in Q2 2017.
  • Emory University opened 16 new positions and closed 5 in Q2 2017.
  • Emory University's portfolio value rose 6.8% quarter-over-quarter to $113M.

Based on Emory University's 13F filing for Q2 2017, filed 10 Aug 2017.